Peter Palese

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

NPJ vaccines

Science translational medicine

Vaccines

Nature medicine

Icahn School of Medicine at Mount Sinai

University of Vienna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Icahn School of Medicine at Mount Sinai

United States

Professor :: Department of Microbiology

Icahn School of Medicine at Mount Sinai

United States

Associate Professor :: Department of Microbiology

Icahn School of Medicine at Mount Sinai

United States

Assistant Professor :: Department of Microbiology

Roche Institute of Molecular Biology

United States

Postdoctoral Fellow :: Department of Cell Biology

Education History

University of Vienna

Austria

PHD :: Chemistry

Publications

Raveen Rathnasinghe, Lauren A Chang, Rebecca Pearl, Sonia Jangra, Amy Aspelund, Alaura Hoag, Soner Yildiz, Ignacio Mena, Weina Sun, Madhumathi Loganathan, Nicholas Alexander Crossland, Hans P Gertje, Anna Elise Tseng, Sadaf Aslam, Randy A Albrecht, Peter Palese, Florian Krammer, Michael Schotsaert, Thomas Muster, Adolfo García-Sastre
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity. NPJ vaccines 9 (1) (2024)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz Stern, Yolanda López-Vidal, Alejandro E Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino Lopez-Macias, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. NPJ vaccines 8 (1) (2023)
Kristien Van Reeth, Anna Parys, José Carlos Mancera Gracia, Ivan Trus, Koen Chiers, Philip Meade, Sean T H Liu, Peter Palese, Florian Krammer, Elien Vandoorn
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine. Nature communications 14 (1) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz Stern, Yolanda López-Vidal, Alejandro E Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino Lopez-Macias, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. NPJ vaccines 8 (1) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Alicia T Widge, Amelia Ruth Hofstetter, Katherine V Houser, Seemal F Awan, Grace L Chen, Maria C Burgos Florez, Nina M Berkowitz, Floreliz Mendoza, Cynthia S Hendel, LaSonji A Holman, Ingelise J Gordon, Preeti Apte, C Jason Liang, Martin R Gaudinski, Emily E Coates, Larisa Strom, Diane Wycuff, Sandra Vazquez, Judy A Stein, Vrc Production Program, William C Adams, Kevin Carlton, Rebecca A Gillespie, Adrian Creanga, Michelle C Crank, Sarah F Andrews, Mike Castro, Leonid A Serebryannyy, Sandeep R Narpala, Christian Hatcher, Bob C Lin, Sarah O'Connell, Alec W Freyn, Victoria C Rosado, Raffael Nachbagauer, Peter Palese, Masaru Kanekiyo, Adrian B McDermott, Richard A Koup, Lesia K Dropulic, Barney S Graham, John R Mascola, Julie E Ledgerwood, null null
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Science translational medicine 15 (692) (2023)
Eduard Puente-Massaguer, Kirill A Vasilyev, Annika Beyer, Madhumathi Loganathan, Benjamin Francis, Michael J Scherm, Guha Asthagiri Arunkumar, Irene González Domínguez, Xueyong Zhu, Ian A Wilson, Lynda Coughlan, Weina Sun, Peter Palese, Florian Krammer
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice. Science advances 9 (37) (2023)
Teresa A Aydillo Gomez, Ana Silvia Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D Nair, Chiara Mariottini, Stuart C Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. NPJ vaccines 7 (1) (2022)
Teresa A Aydillo Gomez, Ana Silvia Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D Nair, Chiara Mariottini, Stuart C Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. NPJ vaccines 7 (1) (2022)
Katherine V Houser, Grace L Chen, Cristina Carter, Michelle C Crank, Thuy A Nguyen, Maria Claudia Burgos Florez, Nina M Berkowitz, Floreliz Mendoza, Cynthia Starr Hendel, Ingelise J Gordon, Emily E Coates, Sandra Vazquez, Judy Stein, Christopher L Case, Heather Lawlor, Kevin Carlton, Martin R Gaudinski, Larisa Strom, Amelia Ruth Hofstetter, C Jason Liang, Sandeep Narpala, Christian Hatcher, Rebecca A Gillespie, Adrian Creanga, Masaru Kanekiyo, Julie E Raab, Sarah F Andrews, Yi Zhang, Eun Sung Yang, Lingshu Wang, Kwanyee Leung, Wing-Pui Kong, Alec W Freyn, Raffael Nachbagauer, Peter Palese, Robert T Bailer, Adrian B McDermott, Richard A Koup, Jason G Gall, Frank Arnold, John R Mascola, Barney S Graham, Julie E Ledgerwood, null null
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nature medicine 28 (2) (2022)
Teresa A Aydillo Gomez, Ana Silvia Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D Nair, Chiara Mariottini, Stuart C Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. NPJ vaccines 7 (1) (2022)
Teresa A Aydillo Gomez, Ana Silvia Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D Nair, Chiara Mariottini, Stuart C Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. NPJ vaccines 7 (1) (2022)
Yeu-Yang Tseng, Chih-Ying Kuan, Masaki Mibayashi, Chi-Jene Chen, Peter Palese, Randy A Albrecht, Wei-Li Hsu
Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria Targeting. Viruses 13 (10) (2021)
Jenna J Guthmiller, Julianna Han, Lei Li, Alec W Freyn, Sean T H Liu, Olivia Stovicek, Christopher T Stamper, Haley L Dugan, Micah E Tepora, Henry A Utset, Dalia J Bitar, Natalie J Hamel, Siriruk Changrob, Nai-Ying Zheng, Min Huang, Florian Krammer, Raffael Nachbagauer, Peter Palese, Andrew B Ward, Patrick C Wilson
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Science translational medicine 13 (596) (2021)
Jenna J Guthmiller, Julianna Han, Henry A Utset, Lei Li, Linda Yu-Ling Lan, Carole Henry, Christopher T Stamper, Meagan McMahon, George O'Dell, Monica L Fernández-Quintero, Alec W Freyn, Fatima Amanat, Olivia Stovicek, Lauren Gentles, Sara T Richey, Alba Torrents de la Peña, Victoria Rosado, Haley L Dugan, Nai-Ying Zheng, Micah E Tepora, Dalia J Bitar, Siriruk Changrob, Shirin Strohmeier, Min Huang, Adolfo García-Sastre, Klaus Roman Liedl, Jesse D Bloom, Raffael Nachbagauer, Peter Palese, Florian Krammer, Lynda Coughlan, Andrew B Ward, Patrick C Wilson
Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature 602 (7896) (2021)
Wen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, Shirin Strohmeier, Alicia Solórzano, Francesco Berlanda-Scorza, Bruce L Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer, Randy A Albrecht
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model. Vaccines 9 (1) (2021)
Weina Sun, Yonghong Liu, Fatima Amanat, Irene González Domínguez, Stephen McCroskery, Stefan A Slamanig, Lynda Coughlan, Victoria Rosado, Nicholas Lemus, Sonia Jangra, Raveen Rathnasinghe, Michael Schotsaert, Jose L Martinez, Kaori Sano, Ignacio Mena, Bruce L Innis, Ponthip Wirachwong, Duong Huu Thai, Ricardo Das Neves Oliveira, Rami Scharf, Richard Hjorth, Rama Raghunandan, Florian Krammer, Adolfo García-Sastre, Peter Palese
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nature communications 12 (1) (2021)
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, David I Bernstein, Jeffrey Guptill, Emmanuel B Walter, Franceso Berlanda-Scorza, Daniel Stadlbauer, Patrick C Wilson, Teresa Aydillo, Mohammad Amin Behzadi, Disha Bhavsar, Carly Bliss, Christina Capuano, Juan Manuel Carreño, Veronika Chromikova, Carine Claeys, Lynda Coughlan, Alec W Freyn, Christopher Gast, Andres Javier, Kaijun Jiang, Chiara Mariottini, Meagan McMahon, Monica McNeal, Alicia Solórzano, Shirin Strohmeier, Weina Sun, Marie Van der Wielen, Bruce L Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nature medicine 27 (1) (2020)
Weina Sun, Stephen McCroskery, Wen-Chun Liu, Sarah R Leist, Yonghong Liu, Randy A Albrecht, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schaefer, Kenneth H Dinnon, Bruce L Innis, Adolfo García-Sastre, Florian Krammer, Ralph S Baric, Peter Palese
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. bioRxiv : the preprint server for biology (2020)
Weina Sun, Sarah R Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schäfer, Kenneth H Dinnon, Adolfo García-Sastre, Florian Krammer, Ralph S Baric, Peter Palese
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate. bioRxiv : the preprint server for biology (2020)
Weina Sun, Stephen McCroskery, Wen-Chun Liu, Sarah R Leist, Yonghong Liu, Randy A Albrecht, Stefan A Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schaefer, Kenneth H Dinnon, Bruce L Innis, Adolfo García-Sastre, Florian Krammer, Ralph S Baric, Peter Palese
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine. Vaccines 8 (4) (2020)
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad Amin Behzadi, Damien Friel, Arvind Rajabhathor, Angela Choi, Randy A Albrecht, Muriel Debois, Adolfo García-Sastre, Ronan Nicolas Rouxel, Weina Sun, Peter Palese, Corey P Mallett, Bruce L Innis, Florian Krammer, Carine Claeys
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts. NPJ vaccines 4 (2019)

Peter Palese.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Palese